Paul Midgley
Paul Midgley is principal consultant, Wilmington Healthcare
HSJ PartnersGuidance on bladder cancer needs to be more specific still
Efforts to reduce variation in treatment for bladder cancer are welcome, but panellists at a recent roundtable event spoke of the need to develop more specific approaches to target patients at the highest risk of poor outcomes
CommentHow can pharma support NHS service change?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, find some answers in NHS England guidance for commissioners